相关实验视频

Updated: Jul 15, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K

血细胞状尿瘤的分子特征和对治疗影响的影响

Kristin Weiss1, Kathryn H Gessner2, Alysen Demzik2

  • 1University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Cancer treatment and research communications
|November 21, 2023
PubMed
概括

基因组洞察力正在彻底改变膀癌症的治疗方法,使个性化医疗成为可能. 本综述探讨了一个罕见的变体 - - 血细胞状尿癌的独特分子特征及其治疗影响.

关键词:
膀癌是一种癌症.分子表征的分子表征.血细胞类型的细胞.尿路细胞癌是什么意思

更多相关视频

Cell-Free DNA Integrity Analysis in Urine Samples07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

13.8K
Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.2K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...